MedTrace Logo

A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors

NCT00706875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2018-04-30

No results posted yet for this study

Summary

The purpose of this study is to collect information on the effects of treatment for gestational trophoblastic disease (GTD). We plan to use the findings from this study to better understand GTD survivors' health and quality of life.

We would like to know more about the health, quality of life and pregnancies of women treated for GTD. This information will be used to try and improve the treatments for women who have this disease.

Conditions

  • Uterine Cancer
  • Cervix Uteri Nos
  • Gestational Trophoblastic Disease

Interventions

BEHAVIORAL

questionnaire

A patient questionnaire, which includes validated instruments. Data collection methods are as follows: * In person at the medical appointment * Over the telephone * Mailed with self-addressed return envelope and prepaid postage * E-mailed and returned by e-mail, fax or self-addressed envelope and pre-paid postage

BEHAVIORAL

questionnaire

A patient questionnaire, which includes validated instruments. Data collection methods are as follows: * In person at the medical appointment * Over the telephone * Mailed with self-addressed return envelope and prepaid postage * E-mailed and returned by e-mail, fax or self-addressed envelope and pre-paid postage

Sponsors & Collaborators

Principal Investigators

  • Elizabeth Jewell, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00706875 on ClinicalTrials.gov